
Tunneling nanotubes form connections between brain cells that express Rhes, a protein linked to Huntington’s disease.
Image Credit: Courtesy of Florida Atlantic University
Scientific Frontline: Extended "At a Glance" Summary: Tunneling Nanotubes in Huntington's Disease Progression
The Core Concept: Brain cells utilize microscopic, tube-like structures known as "tunneling nanotubes" to physically transfer toxic mutant huntingtin proteins to neighboring cells, thereby driving the progression of Huntington's disease.
Key Distinction/Mechanism: Unlike traditional chemical signaling that relies on diffusion across extracellular space, tunneling nanotubes function as direct, physical bridges that allow for the "hand-delivery" of cellular materials. The formation of these pathological highways is driven by a newly discovered molecular partnership at the cell membrane between the Rhes protein and SLC4A7, a bicarbonate transporter typically responsible for regulating internal cellular acidity.
Major Frameworks/Components:
- Tunneling Nanotubes: Microscopic cellular extensions that act as direct conduits for intercellular material transfer.
- Mutant Huntingtin Protein: The toxic biological material responsible for the cellular damage and death characteristic of Huntington's disease.
- Rhes Protein: A protein heavily implicated in Huntington's disease pathology that initiates structural cellular changes.
- SLC4A7 Transporter: A bicarbonate transporter that physically binds to Rhes to construct the nanotube infrastructure.



.jpg)
.jpg)
.jpg)







.jpg)


.jpg)

